Smartleaf Asset Management
LAB icon

Smartleaf Asset Management’s Standard BioTools LAB Stock Holding History

Smartleaf Asset Management’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-789
Closed -$590 – 3737
2026
Q2 		$590 Hold
789
– – ﹤0.01% 3175
2026
Q1 		$727 Sell
789
-3,806
-83% -$4.61K ﹤0.01% 3169
2025
Q4 		$5.74K Buy
4,595
+413
+10% +$555 ﹤0.01% 2650
2025
Q3 		$5.31K Buy
4,182
+3,393
+430% +$4.44K ﹤0.01% 2360
2025
Q2 		$938 Sell
789
-2,526
-76% -$2.8K ﹤0.01% 2489
2025
Q1 		$3.78K Buy
3,315
+3,087
+1,354% +$4.33K ﹤0.01% 2278
2024
Q4 		$403 Buy
+228
New +$425 ﹤0.01% 2809

Other funds holding LAB

Hollow Brook Wealth Management
Hollow Brook Wealth Management Katonah, New York $575M AUM 19.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Peapod Lane Capital
Peapod Lane Capital Bedford Hills, New York $134M AUM 63.91% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
STALEY CAPITAL ADVISERS
STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.67B AUM 20.47% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Oppenheimer & Co
Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return
Johnson & Johnson
Johnson & Johnson New Brunswick, New Jersey $762M AUM 69.66% 1-Year Est. Return
State of Wyoming
State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return

Smartleaf Asset Management's LAB Position: Q3 2026 in Review

Smartleaf Asset Management sold out of Standard BioTools (LAB) in Q3 2026, closing a stake of 789 shares — an estimated $590 sold.

Smartleaf Asset Management first reported a position in LAB in Q4 2024 and held it in 7 quarters. The position peaked at $5.74K in Q4 2025. 37 funds tracked by Wall St. Rank hold LAB as of Q3 2026.

  • Smartleaf Asset Management reported no remaining Standard BioTools position as of Q3 2026 after selling out during the quarter.
  • Smartleaf Asset Management sold 789 Standard BioTools shares in Q3 2026, an estimated $590.
  • Smartleaf Asset Management first reported a position in Standard BioTools in Q4 2024 and held it in 7 quarters.
  • Smartleaf Asset Management's Standard BioTools position peaked at $5.74K in Q4 2025.
  • 37 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2026.

Based on Smartleaf Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.